Increased TMEM16A Involved in Alveolar Fluid Clearance After Lipopolysaccharide Stimulation

Honglin Li1, Xixin Yan2, Rongqin Li3

  • 1Department of Respirology, The Second Hospital of Hebei Medical University, No. 215, West Heping Road, Shijiazhuang, Hebei, 050000, China.

Inflammation
|February 23, 2016
PubMed
Abstract

Insights

Lipopolysaccharide (LPS) increases transmembrane protein 16A (TMEM16A) expression in lung cells and tissue, suggesting TMEM16A acts protectively in acute lung injury (ALI). Further research is needed to confirm its role.

Area of Science:

  • Cellular biology
  • Molecular biology
  • Physiology

Background:

  • Transmembrane protein 16A (TMEM16A) is crucial for epithelial functions like fluid secretion and ion homeostasis.
  • Lipopolysaccharide (LPS), from Gram-negative bacteria, is a key factor in acute lung injury (ALI).

Purpose of the Study:

  • To investigate LPS effects on TMEM16A expression in LA795 cells and mouse lung tissue.
  • To explore the underlying mechanisms of LPS-induced TMEM16A modulation and its role in ALI.

Main Methods:

  • Quantitative analysis of TMEM16A expression using RT-PCR and Western blot.
  • Functional assessment via RNA interference and electrophysiology.
  • Investigation of signaling pathways, including Akt phosphorylation.

Main Results:

  • LPS stimulation significantly upregulated TMEM16A expression in both LA795 cells and mouse lung tissue, particularly in alveolar epithelium.
  • LPS enhanced TMEM16A-mediated currents in LA795 cells.
  • LPS treatment increased Akt phosphorylation and TMEM16A expression concurrently.

Conclusions:

  • TMEM16A expression is upregulated by LPS in lung tissues.
  • TMEM16A may function as a protective protein in LPS-induced ALI.
  • Inhibition of TMEM16A exacerbates LPS-induced alveolar fluid clearance impairment.